Clinical Trials
9 trialsNCT00004868 2018-06-27
SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Completed
NCT00006002 2013-09-05
SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy
University of Chicago
Phase 2 Completed
NCT00026377 2013-09-05
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
University of Chicago
Phase 1 Completed
NCT00006013 2013-07-11
SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma
Fox Chase Cancer Center
Phase 2 Completed
NCT00006384 2011-10-20
SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
City of Hope Medical Center
Phase 2 Completed
NCT00005642 2010-06-11
SU5416 in Treating Patients With Advanced Solid Tumors
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00005822 2010-06-11
SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00005647 2010-06-10
SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00006257 2010-01-13
SU5416 and Paclitaxel in Treating Patients With Advanced Cancer
City of Hope Medical Center
Phase 1 Completed